newsfilter
← Latest News
GlobeNewswire·

23andMe Launches New Genetic Report on Bipolar Disorder

ME

SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME), a leading human genetics and biopharmaceutical company, today released a new genetic Bipolar Disorder report (Powered by